Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
May 17, 2021
Document Date
Apr 19, 2021
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
NICHOLS DAVID WAYNE